Canadian Journal of Gastroenterology and Hepatology

Canadian Journal of Gastroenterology and Hepatology / 1991 / Article

Clinical Gastroenterology | Open Access

Volume 5 |Article ID 393429 | https://doi.org/10.1155/1991/393429

Yaron Niv, "The Prevalence of Crohn’s Disease in the Israeli Kibbutz Population", Canadian Journal of Gastroenterology and Hepatology, vol. 5, Article ID 393429, 3 pages, 1991. https://doi.org/10.1155/1991/393429

The Prevalence of Crohn’s Disease in the Israeli Kibbutz Population

Received03 Jan 1991
Accepted25 Mar 1991

Abstract

An epidemiological study of Crohn’s disease was performed in 279 Israeli Kibbutzim (rural communities) (population 121,403). The prevalence on December 31, 1987 was 25.53 per 100,000 population. When the data were stratified according to ethnic group, the highest point prevalence was found in Asian/African-born Jews (41.76 per 100,000 population), greater than in Israeli-born, or European/American-born Kibbutz members (38.92 and 17.35 cases per 100,000 population, respectively). There were 15 women and 16 men (female to male ratio 0.94). The average age of patients was 45 years in the survey year, and 35 years at diagnosis. Terminal ileitis was found in 69%, ileocolitis in 19%, and colitis in 12%. Probable complications of Crohn’s disease were observed in 10 cases (32%). Anemia was demonstrated in two cases (6%). The high rate of Crohn’s disease prevalence among Israeli-born versus European/American-born Kibbutz members may point to a role for environmental factors in the etiology of the disease.

Copyright © 1991 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views63
Downloads218
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.